產品詳情
簡單介紹：
Anti-CIDEB抗體產品質量穩定，實驗效果明顯，貨期快，價格優惠，歡迎垂詢訂購！我公司長期供應**組化抗體、WB抗體、**組化試劑盒和抗體試驗所需全部相關試劑、熒光標記抗體、單克隆抗體、多克隆抗體、各種標記的二抗IgG/IgM/IgD/IgA等科研實驗抗體。Anti-CIDEB抗體用于**組化實驗,WB實驗,相應的標記抗體有HRP標記抗體,FITC標記,BIO等。
詳情介紹：
Rabbit Anti-CIDEB
Cat. Number:
Anti-CIDEB抗體KL-0716R
Quantity size:
0.2ml
Concentration:
1mg/ml Buffer = 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.
Background:
Apoptosis is related toAnti-CIDEB抗體 many diseases and induced by a family of cell death receptors and their ligands. Cell death signals are transduced by death domain containing adapter molecules and members of the caspase family of proteases. These death signals finally cause the degradation of chromosomal DNA by activated DNase. DFF45/ICAD has been identified as an inhibitor of caspase activated DNase DFF40/CAD. DFF45 related proteins CIDE A and CIDE B were recently identified. CIDE contains a new type of domain termed CIDE N, which has high homology with the regulatory domains of DFF45/ICAD and DFF40/CAD. Expression of CIDE B induces apoptosis, which is inhibited by DFF45. CIDE B is a DFF45 inhibitable effector that promotes cell death and DNA fragmentation. CIDE B is expressed mainly in liver and small intestine and at lower levels in spleen, Anti-CIDEB抗體colon, kidney, peripheral blood lymphocytes, and bone marrow.
Also known as:
cell death activator CIDE-B; Cell death activator CIDE B; Cell death inducing DFFA like effector B; CIDEB_HUMAN; cell death-inducing DFFA-like effector B; Cide-b.
Specificity:
●
Rabbit Polyclonal IgG, Anti-CIDEB抗體affinity purified by Protein A.
●
Reacts with: Human, Mouse, Rat, Dog, Pig, Cow, Horse, .
●
Immunogen: KLH conjugated synthetic peptide derived from human CIDEB (115-160aa).
●
Predicted Molecular Weight: 24kDa.
Storage:
Shipped at 4℃, Store at -20℃ (Avoid repeated freeze/thaw cycles).
Application:
WB=1:100-500 ELISA=1:500-1000 IHC-P=1:100-500 IHC-F=1:100-500 IF=1:100-500
Not yet tested in other applications.
Optimal working dilutions must be Anti-CIDEB抗體determined by the end user.
Not yet tested in other applications.
Optimal working dilutions must be Anti-CIDEB抗體determined by the end user.
kl015Hu01 α1-抗胰糜蛋白酶(α1ACT)多克隆抗體 Polyclonal Antibody to Alpha-1-Antichymotrypsin (a1ACT)
kl018Bo01 α-乳清蛋白(αLA)多克隆抗體 Polyclonal Antibody to Alpha-Lactalbumin (aLA)
kl018Hu01 α-乳清蛋白(αLA)多克隆抗體 Polyclonal Antibody to Alpha-Lactalbumin (aLA)
kl019Hu01 血管生成素樣蛋白4(ANGPTL4)多克隆抗體 Polyclonal Antibody to Angiopoietin Like Protein 4 (ANGPTL4)
kl019Mu01 血管生成素樣蛋白4(ANGPTL4)多克隆抗體 Polyclonal Antibody to Angiopoietin Like Protein 4 (ANGPTL4)
kl019Ra01 血管生成素樣蛋白4(ANGPTL4)多克隆抗體 Polyclonal Antibody to Angiopoietin Like Protein 4 (ANGPTL4)
kl020Hu01 淀粉樣前體蛋白(APP)多克隆抗體 Polyclonal Antibody to Amyloid Precursor Protein (APP)
kl020Ra01 淀粉樣前體蛋白(APP)多克隆抗體 Polyclonal Antibody to Amyloid Precursor Protein (APP)
kl021Hu01 連環蛋白β1(CTNNβ1)多克隆抗體 Polyclonal Antibody to Catenin Beta 1 (CTNNb1)
kl021Mu01 連環蛋白β1(CTNNβ1)多克隆抗體 Polyclonal Antibody to Catenin Beta 1 (CTNNb1)
kl021Ra01 連環蛋白β1(CTNNβ1)多克隆抗體 Polyclonal Antibody to Catenin Beta 1 (CTNNb1)
kl025Hu01 神經介素U(NMU)多克隆抗體 Polyclonal Antibody to Neuromedin U (NMU)
kl027Hu01 泛素激活酶樣蛋白(UBE1L)多克隆抗體 Polyclonal Antibody to Ubiquitin Activating Enzyme E1 Like Protein (UBE1L)
kl032Hu01 磷脂酰肌醇蛋白聚糖1(GPC1)多克隆抗體 Polyclonal Antibody to Glypican 1 (GPC1)
kl032Mu01 磷脂酰肌醇蛋白聚糖1(GPC1)多克隆抗體 Polyclonal Antibody to Glypican 1 (GPC1)
kl033Hu01 Dickkopf相關蛋白2(DKK2)多克隆抗體 Polyclonal Antibody to Dickkopf Related Protein 2 (DKK2)
kl036Hu01 生長**受體(GHR)多克隆抗體 Polyclonal Antibody to Growth Hormone Receptor (GHR)
kl038Hu01 谷氨酸半胱氨酸連接酶(GCLM)多克隆抗體 Polyclonal Antibody to Glutamate Cysteine Ligase, Modifier Subunit (GCLM)
kl039Hu01 表面活性物質關聯蛋白D(SPD)多克隆抗體 Polyclonal Antibody to Surfactant Associated Protein D (SPD)
kl039Mu01 表面活性物質關聯蛋白D(SPD)多克隆抗體 Polyclonal Antibody to Surfactant Associated Protein D (SPD)
kl039Ra01 表面活性物質關聯蛋白D(SPD)多克隆抗體 Polyclonal Antibody to Surfactant Associated Protein D (SPD)
kl040Hu01 波形蛋白(VIM)多克隆抗體 Polyclonal Antibody to Vimentin (VIM)
kl040Mu01 波形蛋白(VIM)多克隆抗體 Polyclonal Antibody to Vimentin (VIM)
